破除误区：甲状腺癌并非全是“懒癌”，复发风险不容忽视

Core Insights - The incidence of thyroid cancer in China is rapidly increasing, with 466,100 new cases reported in 2024, making it the third most common malignant tumor, particularly affecting younger populations [1][3] - There is a prevalent misconception among the public that thyroid cancer is a "lazy cancer," leading to insufficient awareness regarding postoperative follow-up and long-term management [1][4] - Despite a high survival rate of 92.9% over five years, the recurrence rate can reach 20% post-surgery, necessitating a shift towards comprehensive management strategies [4][6] Group 1: Incidence and Demographics - In the 15-29 age group, thyroid cancer has the highest number of new cases among all cancers [1] - The female incidence rate of thyroid cancer is approximately 49.4 per 100,000, with a 20% annual increase since 2000, making it one of the most common cancers among women in China [3][4] Group 2: Misconceptions and Risks - The term "lazy cancer" is deemed unscientific, as it overlooks the existence of highly malignant types of thyroid cancer that can progress rapidly and pose life-threatening risks [1][3] - The misconception leads to delays in diagnosis and treatment, emphasizing the need for public education on the seriousness of thyroid cancer [2][4] Group 3: Management and Follow-Up - Postoperative management is crucial, with a need for dynamic assessment based on risk stratification (high, medium, low) to determine follow-up frequency and treatment [6][8] - The use of recombinant human thyroid-stimulating hormone (rh-TSH) for dynamic evaluation is recommended to improve patient compliance and long-term survival rates [7][8] Group 4: Treatment and Lifestyle Recommendations - Patients are advised against self-adjusting medication dosages and should follow medical guidance for long-term thyroid hormone suppression therapy [8] - A balanced diet and lifestyle, including regular exercise and stress management, are encouraged to reduce recurrence risks [8]